NL-OMON34257已完成不适用
The vascular and metabolic effects of sunitinib in patients with metastatic renal cell carcinoma - SUMAVA
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Subject is able and willing to sign the Informed Consent Form
- •Age 18 years or older
- •WHO performance status 0-2
- •Life expectancy >= 12 weeks
- •mRCC patients in which the treatment of choice is sunitinib
排除标准
- •1) Use of corticosteroids
- •2) Any evidence of severe or uncontrolled diseases other than renal cell carcinoma eg, unstable or uncompensated respiratory, cardiac, hepatic or renal disease.
- •3) Known risk of the patient transmitting HIV, hepatitis B or C via infected blood
- •4) Patients being treated with oral anticoagulants if to be included in group A.
研究者
相似试验
已完成
不适用
The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell CarcinomaRenal FunctionInsulin SensitivityHypertensionRenal Cell CarcinomaNCT01227213Radboud University Medical Center20
已完成
不适用
Cardiovascular Effects of Sunitinib Therapy (CREST)Renal Cell Carcinoma 4NCT01370109Abramson Cancer Center at Penn Medicine98
已完成
不适用
Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)Renal Cell Cancer MetastaticSodium ImbalanceHypertensionNCT04368546Charite University, Berlin, Germany6
撤回
4 期
Study on the influence of sunitinib and sorafenib on cognitive functioning a cross sectional study (UMCNONCO200901)gastro intestinal stromacel tumorkidney cancer10038364GISTNL-OMON32837niversitair Medisch Centrum Sint Radboud80
招募中
不适用
The influence of sunitinib on contractility of human atrial trabeculaecardiotoxicity10019280Heart failureNL-OMON34277niversitair Medisch Centrum Sint Radboud60